Ablative and Existing Threshold Dosimetry for Hepatic Metastatic Disease

Key Points

• The research aims to review dosimetric approaches and clinical outcomes of yttrium-90 radiation segmentectomy for hepatic metastatic disease.
• Evaluated current evidence on dosimetric approaches for metastatic liver disease.
• Reviewed clinical outcomes associated with radiation segmentectomy.
• Assessed tumor-absorbed dose thresholds for radioembolization.
• Identified established dosimetric strategies for hepatocellular carcinoma.
• Examined less defined approaches for hepatic metastases.
• Highlighted the importance of dose thresholds to improve treatment efficacy.

Abstract